Don't forget this
Published: Mon, 08/29/16
![]() Hello fellow investors / traders, We first alerted you to PositiveID Corp (PSID) back in May this year. And while we were a few days early, it went on to gain over 100% from our alert price in the proceeding days.
Now the setup in PSID looks better than ever with a much lower entry price, a major news catalyst that hit the wires on Friday, and a technically oversold chart that looks ripe for a bounce. First let's focus on the most exciting chart I've seen in a while. In April, PSID traded well below its 50 day moving average (DMA) and then bounced back 35% higher to test this level in the pursuing days. In May it once again traded well below its 50 and 200 DMA, and then it snapped back slicing right through the shorter term 50 DMA, subsequently testing its higher 200 DMA - a 213% move higher on the bounce. Then in July it did the same thing, bouncing some 112% higher in just a couple of days back to test its 50 DMA. Fast forward to today... PSID has once again been trading well below its major moving averages, and with its prolonged oversold RSI reading, we think another bounce is on the cards - to once again test its 50 DMA. Such a move could deliver 100% gains. Now this is not just some random speculation. Our analysis is purely based off the actual recent trading history in PSID. And because of the Friday's news, and other recent news catalysts, such as a huge $1.7 million year-on-year revenue increase in their latest earnings announcement, we think momentum could rapidly shift for an explosive upside move. ![]() Now there is even more to like about PSID than just the chart. The company has been releasing a lot of positive news recently which should get investors excited. As per the Company's press release just a couple weeks ago, revenue increased to $1.8 million for the three months ended June 30, 2016, up from $51 thousand for the three months ended June 30, 2015. The increased revenue is attributable to the Company’s December 2015 acquisitions of E-N-G Mobile Systems, Inc. (“ENG”), a leader in the mobile labs market, and Thermomedics Inc., which markets the FDA cleared Caregiver® non-contact thermometer. Revenue for the six months ended June 30, 2016 increased to $3.5 million, up from $182 thousand for the six months ended June 30, 2015. “We remain very encouraged by the performance of the businesses we acquired in December 2015,” stated William J. Caragol, Chairman and CEO of PositiveID. “ENG has generated the majority of our revenues year-to-date, and both ENG and our Caregiver business have strong and improving pipelines and backlog." In addition, PSID announced Friday that it has completed its acquisition of Thermomedics Inc., the designer and marketer of the Caregiver® infrared, non-contact thermometer, which is FDA-cleared for clinical use. Caregiver is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone. The global market for temperature monitoring devices is forecast to reach $1 billion by 2020, with infrared thermometers experiencing the fastest growth driven in part by concerns over the spread of highly infectious diseases like Ebola, according to Global Industry Analysts, Inc. PositiveID Corp (PSID) is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins. PositiveID's Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time polymerase chain reaction (PCR) chemistry. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets by enabling hospitals, physicians and other providers to save lives and fight disease. In addition, PSID markets Caregiver(R), the first FDA-cleared non-contact thermometer that uses infrared technology. PSID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security You can learn more about PSID at their website http://www.psidcorp.com/ According to OTCMarkets.com, PSID has a tiny market cap of just over $1 million and the company just announced very strong year over year revenue growth. PSID has a technically oversold chart, which if history is anything to go by, we think is ready to bounce significantly higher in the short term. In fact, we believe based on the technical indicators and news catalysts, PSID could be a major gainer in the coming days/weeks. Make sure you do your DD on PSID and be ready to play today. Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here. ShiznitStocks.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead ShiznitStocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. ShiznitStocks.com does not offer such advice or analysis, and ShiznitStocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, ShiznitStocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, ShiznitStocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. ShiznitStocks.com is not responsible for any claims made by the companies advertised herein. ShiznitStocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in ShiznitStocks.com statements and opinions and such statements and opinions cannot be considered independent. ShiznitStocks.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, ShiznitStocks.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. ShiznitStocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. ShiznitStocks.com has been compensated two thousand dollars via electronic transfer from a non-affiliated third party for the profile of PSID. ShiznitStocks.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated ShiznitStocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If ShiznitStocks.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services. |